Company profile: Banner Life Sciences
1.1 - Company Overview
Company description
- Provider of pharmaceutical product development and drug processing for human and veterinary use, offering BAFIERTAM, a prescription medicine for relapsing forms of multiple sclerosis (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease) in adults.
Products and services
- Product Development: Banner Life Sciences architects pharmaceutical products for humans and veterinary, focusing on product development activities consistent with its pharmaceutical company emphasis
- Drug Processing Services: Banner Life Sciences produces and processes pharmaceutical drugs for humans and veterinary use, executing processing operations aligned with its pharmaceutical company focus
- BAFIERTAM: A prescription medicine used to treat relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Banner Life Sciences
Aiolos Bio
HQ: United States
Website
- Description: Provider of therapies for respiratory and immune conditions, initially advancing AIO-001, a monoclonal antibody for moderate-to-severe asthma dosed every 6 months. Offers vaccines for meningitis, shingles, RSV, flu, and polio; specialty and general medicines for HIV, asthma, COPD, lupus, cancer, and skin diseases; conducts infectious disease research and develops respiratory/immunology solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aiolos Bio company profile →
Medaspis
HQ: Germany
Website
- Description: Provider of professional expertise in healthcare, pharmaceuticals, IT, and logistics, backed by long-standing experience across these fields.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medaspis company profile →
LGM Pharma
HQ: United States
Website
- Description: Provider of cGMP API sourcing and distribution with integrated supply chain security and regulatory support. Services include CDMO development and manufacturing from concept to commercialization, analytical method development, validation and stability testing, regulatory submissions, logistics for import and clearance, and suppository formulation and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LGM Pharma company profile →
Ascential Technologies
HQ: United States
Website
- Description: Provider of design, development, testing, manufacturing, and automation solutions for medical devices and life sciences; vehicle testing and automation (wheel alignment, emissions, driver assistance systems) via Burke Porter; and industrial sectors like HVAC and energy, offering test and measurement systems, balancing equipment, lifecycle services, and lab products such as dynamometers and NVH testers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ascential Technologies company profile →
Oncodesign
HQ: France
Website
- Description: Provider of precision medicine-driven oncology preclinical CRO services and biopharmaceutical R&D, developing anticancer therapies and leveraging platforms such as Nanocyclix for selective kinase inhibitors and OncoSNIPER AI for resistant patient stratification. Pipeline includes OPM-101 (RIPK2, IBD), OPM-102 (RIPK2, inflammation-related tumors), and an LRRK2 program (Parkinson’s), plus the IMODI cluster for cancer models and microbiota studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oncodesign company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Banner Life Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Banner Life Sciences
2.2 - Growth funds investing in similar companies to Banner Life Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Banner Life Sciences
4.2 - Public trading comparable groups for Banner Life Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →